Background: Post-kala-azar dermal leishmaniasis (PKDL) is a dermal complication of visceral leishmaniasis (VL), which may occur after or during treatment. It has been frequently reported from India and the Sudan, but its occurrence in South America has been rarely reported. It may mimic leprosy and its differentiation may be difficult, since both diseases may show hypo-pigmented macular lesions as clinical presentation and neural involvement in histopathological investigations. The co-infection of leprosy and VL has been reported in countries where both diseases are endemic. The authors report a co-infection case of leprosy and VL, which evolved into PKDL and discuss the clinical and the pathological aspects in the patient and review the li...
BACKGROUND AND AIMS: Lesions of post-kala-azar dermal leishmaniasis (PKDL) usually affect the skin....
Post kala-azar dermal leishmaniasis (PKDL) is a skin manifestation that usually develops after treat...
Background: Cutaneous leishmaniasis (CL) is a major health problem in many parts of Iran, although d...
Post kala-azar dermal leishmaniasis (PKDL), a sequelae of kala-azar is well recognized in our countr...
Abstract Background Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis that occurs 2–3 years...
IntroductionPost-kala-azar dermal leishmaniasis (PKDL) is a skin manifestation that is a late clinic...
Post-kala-azar dermal leishmaniasis (PKDL) is rarely reported in South America. In spite of the fact...
Copyright © 2015 Neena Verma et al. This is an open access article distributed under the Creative Co...
Post-kala-azar dermal leishmaniasis (PKDL) is rarely reported in South America. In spite of the fact...
p. 313-316Post-kala-azar dermal leishmaniasis (PKDL) is rarely reported in South America. In spite o...
Post-kala-azar dermal leishmaniasis (PKDL) is rarely reported in South America. In spite of the fact...
Post-kala-azar dermal leishmaniasis (PKDL) is a dermatologic manifestation that usually occurs after...
The clinical features, pathology, immune responses, diagnosis and treatment of post kala-azar dermal...
kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrosp...
Post kala-azar dermal leishmaniasis (PKDL), a cutaneous sequela of visceral leishmaniasis (VL), deve...
BACKGROUND AND AIMS: Lesions of post-kala-azar dermal leishmaniasis (PKDL) usually affect the skin....
Post kala-azar dermal leishmaniasis (PKDL) is a skin manifestation that usually develops after treat...
Background: Cutaneous leishmaniasis (CL) is a major health problem in many parts of Iran, although d...
Post kala-azar dermal leishmaniasis (PKDL), a sequelae of kala-azar is well recognized in our countr...
Abstract Background Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis that occurs 2–3 years...
IntroductionPost-kala-azar dermal leishmaniasis (PKDL) is a skin manifestation that is a late clinic...
Post-kala-azar dermal leishmaniasis (PKDL) is rarely reported in South America. In spite of the fact...
Copyright © 2015 Neena Verma et al. This is an open access article distributed under the Creative Co...
Post-kala-azar dermal leishmaniasis (PKDL) is rarely reported in South America. In spite of the fact...
p. 313-316Post-kala-azar dermal leishmaniasis (PKDL) is rarely reported in South America. In spite o...
Post-kala-azar dermal leishmaniasis (PKDL) is rarely reported in South America. In spite of the fact...
Post-kala-azar dermal leishmaniasis (PKDL) is a dermatologic manifestation that usually occurs after...
The clinical features, pathology, immune responses, diagnosis and treatment of post kala-azar dermal...
kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrosp...
Post kala-azar dermal leishmaniasis (PKDL), a cutaneous sequela of visceral leishmaniasis (VL), deve...
BACKGROUND AND AIMS: Lesions of post-kala-azar dermal leishmaniasis (PKDL) usually affect the skin....
Post kala-azar dermal leishmaniasis (PKDL) is a skin manifestation that usually develops after treat...
Background: Cutaneous leishmaniasis (CL) is a major health problem in many parts of Iran, although d...